Educational use and medical limits.
Replexium Peptide publishes educational information for adults. Access to the site does not create a doctor-patient relationship. Articles do not diagnose a condition, prescribe a treatment, establish a safe personal-use protocol or guarantee an outcome.
A peptide’s appearance in an article, supplier catalog or assay report does not establish FDA drug approval, eligibility for compounding or suitability for a particular use. Individual clinical decisions require an appropriately qualified healthcare professional.
Use the site lawfully.
Access is permitted for personal, non-commercial informational reading, subject to these terms and applicable law. Misuse includes unlawful activity, attempts to disrupt the site or its security, misrepresentation, infringement and unauthorised exploitation of its content.
The publication’s content and design are subject to applicable intellectual-property rights. Access does not transfer ownership. Rights in quoted works, referenced studies, third-party names and external resources remain with their respective holders.
Copyright concerns can be raised through the contact page, identifying the material and the claimed right. Applicable lawful quotation and other legal exceptions remain relevant.
External resources have their own terms.
Links help readers inspect source material or supplier documentation. The publication does not control an external website’s content, availability, transactions or policies. A ranking is an editorial judgement within its stated scope, not a warranty of another organisation’s performance.
Information has limits.
The site and its content are provided as available, without a guarantee of completeness, accuracy, uninterrupted access or fitness for a particular purpose, to the extent allowed by law. Research and regulatory records can change, and a source can have limitations not visible in a brief summary.
To the extent permitted by applicable law, the existing terms exclude implied warranties and limit liability for losses arising from access, inability to access, reliance on content or third-party resources. Mandatory rights and limits imposed by a reader’s jurisdiction still apply.
Responsibility and disputes.
The existing terms require users, to the extent permitted by law, to defend and indemnify the publication and relevant parties against claims arising from unlawful misuse, infringement or breach of these terms.
The earlier terms specify United States law and individual binding arbitration under American Arbitration Association rules, with a class-action waiver. Those provisions remain subject to applicable mandatory law; no particular state jurisdiction is asserted here.
Access and the agreement.
Access may be suspended or terminated for breach or misuse. If a provision is unenforceable, the remaining provisions continue to the extent permitted by law. These terms and the privacy policy form the site-use agreement.
Continued use is subject to the terms published with the site. Questions about them can be directed through the contact page.